Key facts
- ClearCam’s last known valuation is $30.6M (Mar 2025).
- It has raised $7.6M across 4 recorded rounds; the latest was Seed Round ($500K) in Mar 2025.
- Notable investors include MedTech Innovator, Hale Holdings Group, ACC Bioscience Incubator, Austin Technology Incubator, Buena Vista Angels — 16 tracked in total.
- ClearCam has filed 5 Form Ds with the SEC since 2018, most recently Mar 2025 ($500K sold to 1 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 4 rounds
- ·The complete investor list — 16 names
- ·Watchlist + deal alerts for ClearCam
Funding rounds
4 roundsAbout ClearCam
Developer of medical technologies designed to improve a surgeon's visual field during surgical procedures. The company offers intra-operative lens cleaner that eliminates the need to remove the laparoscope from the body cavity for lens cleaning attaches to the scope and requires no additional supplies, enabling patients, surgeons, and surgical staff to save procedure time and improve safety.
- Sector
- Healthcare
- HQ
- Austin, TX, United States
- Founded
- 2017
- Employees
- 11
- Website
- clearcam-med.com/
- Ownership
- Privately Held (backing)
ClearCam doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in ClearCam shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on ClearCam in its N-PORT filings yet. We sweep new filings monthly.